Track the 엔지켐생명과학 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 엔지켐생명과학 has published 108 insider filings. Market capitalisation: €83.8bn. The latest transaction was disclosed on 1 June 2026 (Other). Among the most active insiders: 윤영배. Every trade is openly available.
108
Insider Decl.
0
Thresholds
€3m
55 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Buys €3m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,504 of 25,927 companies
8.7
score / 100
Value
12
Quality
6
FCF yld-14%
Earn yld-22%
EV/EBITDA·
ROE·
Gross mgn5.0%
Net mgn-27%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.